Omega Healthcare Investors
OHI · NYSEReal Estate Investment Trusts · Fiscal year ends Dec 31
Omega Healthcare Investors reported revenue of $1.2B in the fiscal year ended Dec 2025, up 13.2% from the year before. Net income was $590M. Net debt was $4.2B.
Last 5 fiscal years
Revenue and net income
Income statement
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $878M | $950M | $1.1B | $1.2B |
| Interest expense | $235M | $233M | $236M | $222M | $215M |
| Pre-tax income | $416M | $436M | $255M | $429M | $624M |
| Income tax | $4M | $5M | $6M | $11M | $15M |
| Net income | $428M | $439M | $242M | $406M | $590M |
| Diluted EPS | 1.75 | 1.80 | 1.00 | 1.55 | 1.94 |
| Diluted shares | 244M | 244M | 250M | 270M | 305M |
Balance sheet
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $21M | $297M | $443M | $518M | $27M |
| Goodwill | $651M | $643M | $644M | $644M | $645M |
| Total assets | $9.6B | $9.4B | $9.1B | $9.9B | $10B |
| Long-term debt | $5.3B | $5.3B | $5.1B | $4.8B | $4.3B |
| Total liabilities | $5.5B | $5.6B | $5.4B | $5.2B | $4.6B |
| Shareholders' equity | $3.9B | $3.6B | $3.6B | $4.5B | $5.2B |
Cash flow
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $722M | $626M | $618M | $749M | $879M |
| Depreciation & amortisation | $342M | $332M | $320M | $305M | $325M |
| Stock-based compensation | $21M | $27M | $35M | $37M | $44M |
| Share buybacks | – | $142M | – | – | – |
| Dividends paid | $638M | $633M | $644M | $685M | $780M |
| Dividend per share | 2.68 | 2.68 | 2.68 | 2.68 | 2.68 |
Key ratios
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | −17.4% | 8.1% | 10.7% | 13.2% |
| EPS growth (YoY) | – | 2.9% | −44.4% | 55.0% | 25.2% |
| Net margin | 40.3% | 50.0% | 25.5% | 38.6% | 49.6% |
| Return on equityBlank when equity is negative | 11.0% | 12.2% | 6.8% | 9.0% | 11.4% |
| Cash conversion (CFO ÷ net income) | 1.69x | 1.43x | 2.55x | 1.84x | 1.49x |
| Debt ÷ equity | 1.34x | 1.46x | 1.42x | 1.07x | 0.82x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | $5.2B | $5B | $4.6B | $4.3B | $4.2B |
Recent filings
More in Real Estate Investment Trusts
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.